Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JMIR Perioperative Medicine is Scopus-indexed (Q1, CiteScore 3.5), WoS ESCI, DOAJ. Published by JMIR Publications Inc..
Checked against the index lists dated .
ISSN 2561-9128Verify ISSN ↗
Publisher: JMIR Publications Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Health Professions (miscellaneous) | 14 / 101 | 86th | Q1 |
| Medicine (miscellaneous) | 173 / 466 | 62nd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q1, CiteScore 3.5.
JMIR Perioperative Medicine is Q1 in Health Professions (miscellaneous) (rank 14 of 101) and Q2 in Medicine (miscellaneous) (rank 173 of 466), by CiteScore 2025.
JMIR Perioperative Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.5, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.680, quartile Q1, with an H-index of 8.
JMIR Perioperative Medicine is published by JMIR Publications Inc. Its ISSN is 2561-9128.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
JMIR Perioperative Medicine has an h-index of 21 and a 2-year mean of 2.43 citations per paper (OpenAlex). Its Scopus CiteScore is 3.5, quartile Q1. On 2-year citations it ranks #9 of 97 Scopus journals in Health Professions (miscellaneous).
JMIR Perioperative Medicine published 19 papers in 2025; its busiest recent year was 2022 with 32. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2022–2026), authors are most often from United States (45.6%), Canada (14.4%) and Netherlands (8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.